Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production

Iñigo Angulo, María Belén Jiménez-Díaz, José Francisco García-Bustos, Domingo Gargallo, Federico Gómez de las Heras, María Angeles Muñoz-Fernández, Manuel Fresno

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

Systemic infections caused by fungi after cytoreductive therapies are especially difficult to deal with in spite of currently available antimicrobials. However, little is known about the effects of fungi on the immune system of immunosuppressed hosts. We have addressed this by studying the in vitro T cell responses after systemic infection with Candida albicans in cyclophosphamide-treated mice. After cyclophosphamide treatment, a massive splenic colonization of the spleens, but not lymph nodes, by immature myeloid progenitor (Ly-6G+CD11b+) cells is observed. These cells are able to suppress proliferation of T lymphocytes via a nitric oxide (NO)-dependent mechanism. Systemic infection with a sublethal dose of C. albicans did not cause immunosuppression per se but strongly increased NO-dependent suppression in cyclophosphamide-treated mice, by selective priming of suppressive myeloid progenitors (Ly-6G+CD11b+CD31+CD40+WGA +CD117low/-CD34low/-) for iNOS protein expression. The results indicate that systemic C. albicans infection can augment the effects of immunosuppressive therapies by promoting functional changes in immunosuppressive cells.

Original languageEnglish
Pages (from-to)46-58
Number of pages13
JournalCellular Immunology
Volume218
Issue number1-2
DOIs
Publication statusPublished - 1 Dec 2002
Externally publishedYes

Cite this